http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017005107-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1acdc6e6d893a5b6233f0dd7298730a9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-915
filingDate 2016-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b981aa48571eebbfd64012467d5670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e90ab7fd77fd560ae737823a5af8f6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acbf0b7c51c9041bd8ffdd6acad8f7b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d841df2d251ed25afee158354feaa2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc1bd55b633be0be9acdc729500faac
publicationDate 2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017005107-A1
titleOfInvention Intravascular stent
abstract An intravascular stent (100, 200, 300) comprises a matrix with a hollowed-out area, and at least one development structure (103, 201, 301). Each development structure (103, 201, 301) comprises a fixed body and a development material (105, 208, 307) filled in the fixed body. The fixed body is connected to the matrix, and is at least partially disposed in the hollowed-out area. An envelope enclosed area of all the development materials (105, 208, 307) in each development structure (103, 201, 301) is less than or equal to 2 mm 2 , and a sum of effective areas of all the development materials (105, 208, 307) in each development structure (103, 201, 301) is greater than or equal to 0.15 mm 2 , wherein a ratio of the sum of the effective materials to the envelope enclosed area is greater than or equal to 1:5. The development structure (103, 201, 301) has a desirable development effect, and basically does not affect a pressed holding diameter of the intravascular stent (100, 200, 300).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109984863-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109984864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3721839-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109984864-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109984863-B
priorityDate 2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6758859-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009005858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015018934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010004735-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425762086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16131010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558793

Total number of triples: 56.